The REMEDIAL III study showed that a urine-flow-rate-guided approach carried out by the RenalGuard system is superior to left ventricular end-diastolic pressure-guided hydration to prevent contrast-induced acute kidney injury (CI-AKI) in patients at high risk of suffering CI-AKI, according to the results presented Sunday at Transcatheter Cardiovascular Therapeutics 2019 in San Francisco.